Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cerilliant
McKinsey
Mallinckrodt
Medtronic
Cipla
Chubb
Johnson and Johnson
Harvard Business School

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,061,703

« Back to Dashboard

Summary for Patent: 5,061,703
Title: Adamantane derivatives in the prevention and treatment of cerebral ischemia
Abstract:A method for the prevention and treatment of cerebral ischemia using an adamantane derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 are identical or different, representing hydrogen or a straight or branched alkyl group of 1 to 6 C atoms or, in conjunction with N, a heterocyclic group with 5 or 6 ring C atoms; wherein R.sub.3 and R.sub.4 are identical or different, being selected from hydrogen, a straight or branched alkyl group of 1 to 6 C atoms, a cycloalkyl group with 5 or 6 C atoms, and phenyl; wherein R.sub.5 is hydrogen or a straight or branched C.sub.1 -C.sub.6 alkyl group, or a pharmaceutically-acceptable salt thereof, is disclosed.
Inventor(s): Bormann; Joachim (Frankfurt, DE), Gold; Markus R. (Nauheim, DE), Schatton; Wolfgang (Eschborn, DE)
Assignee: Merz + Co. GmbH & Co. (Frankfurt am Main, DE)
Application Number:07/508,109
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,061,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,061,703

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
89106657Apr 14, 1989

International Patents Family Members for US Patent 5,061,703

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 173356 ➤ Try a Free Trial
Denmark 91690 ➤ Try a Free Trial
Germany 58905637 ➤ Try a Free Trial
Germany 10299048 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Johnson and Johnson
Mallinckrodt
Daiichi Sankyo
UBS
Cantor Fitzgerald
Fuji
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.